David Branigan, Intellectual Property Watch; Report – Patent Abuse A Leading Cause Of High Drug Prices In US
"The report, “Overpatented, Overpriced: How Excessive Pharmaceutical Patenting is Extending Monopolies and Driving up Drug Prices,” was produced by the New York-based Initiative for Medicines, Access & Knowledge (I-MAK)...
“Spanning twelve drugmakers and a range of conditions such as cancer,
arthritis, stroke, and diabetes, the study captures an industry-wide
trend of pharmaceuticals ‘evergreening’ their products with excessive
patents so they can artificially extend monopolies and boost profits—at
the expense of American families and the budgets of public and private
payers around the country,” according to the press release."
Issues and developments related to ethics, information, and technologies, examined in the ethics and intellectual property graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology" will be published in Summer 2025. Kip Currier, PhD, JD
Showing posts with label boosting profits. Show all posts
Showing posts with label boosting profits. Show all posts
Saturday, August 4, 2018
Report – Patent Abuse A Leading Cause Of High Drug Prices In US; Intellectual Property Watch, August 3, 2018
Subscribe to:
Posts (Atom)